Welcome to LookChem.com Sign In|Join Free
  • or
2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL is a chemical compound with the molecular formula C7H4F3NO4. It is a nitrophenol derivative featuring a trifluoromethoxy group attached to the fourth position of the phenol ring. 2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL is recognized for its potential applications in various industries due to its unique chemical structure and properties.

129644-56-0

Post Buying Request

129644-56-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

129644-56-0 Usage

Uses

Used in Pharmaceutical Industry:
2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL is used as a precursor in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows it to be a key intermediate in the production of various medicinal compounds.
Used in Dye Industry:
In the dye industry, 2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL is utilized as a precursor for synthesizing dyes, taking advantage of its chemical properties to create a range of colorants for different applications.
Used in Agrochemical Industry:
2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL is employed as a starting material in the production of agrochemicals, specifically for developing new pesticides or other agricultural chemicals that can improve crop protection and yield.
Used as an Antimicrobial and Antifungal Agent:
2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL has been investigated for its potential use as an antimicrobial and antifungal agent, capitalizing on its ability to inhibit the growth of various microorganisms, which can be beneficial in medical and environmental applications.
Used in the Development of New Materials:
2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL has been studied for its antioxidant properties and is considered for use in the development of new materials that can leverage its chemical reactivity and stability.
Safety Note:
It is crucial to handle 2-NITRO-4-(TRIFLUOROMETHOXY)PHENOL with care due to its toxic nature. It may cause irritation to the skin, eyes, and respiratory system if proper safety measures are not adhered to, emphasizing the need for appropriate protective equipment and handling procedures.

Check Digit Verification of cas no

The CAS Registry Mumber 129644-56-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,6,4 and 4 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 129644-56:
(8*1)+(7*2)+(6*9)+(5*6)+(4*4)+(3*4)+(2*5)+(1*6)=150
150 % 10 = 0
So 129644-56-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F3NO4/c8-7(9,10)15-4-1-2-6(12)5(3-4)11(13)14/h1-3,12H

129644-56-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Nitro-4-(trifluoromethoxy)phenol

1.2 Other means of identification

Product number -
Other names 2-Nitro-4-trifluoromethoxyphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:129644-56-0 SDS

129644-56-0Upstream product

129644-56-0Relevant academic research and scientific papers

INHIBITORS OF HIF PROLYL HYDROXYLASE

-

Page/Page column 166, (2016/04/20)

The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

-

Page/Page column 132-133, (2011/02/18)

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.

HARMFUL ARTHROPOD CONTROL COMPOSITION, AND FUSED HETEROCYCLIC COMPOUND

-

Page/Page column 84-85, (2011/04/13)

Disclosed is a harmful arthropod control composition comprising, as an active ingredient, a fused heterocyclic compound represented by formula (1) [wherein A1 and A2 independently represent a nitrogen atom or the like; R1 and R4 independently represent a halogen atom or the like; R2 and R3 independently represent a halogen atom or the like; R5 and R6 independently represent a linear C1-C6 hydrocarbon group which may be substituted, or the like (provided that both R5 and R6 cannot represent a hydrogen atom simultaneously); and n represents 0 or 1]. The harmful arthropod control composition has an excellent efficacy to control harmful arthropods.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

-

Page/Page column 220-221, (2011/04/25)

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a neonicotinoid compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a neonicotinoid compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

-

Page/Page column 220, (2011/05/06)

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and pyriproxyfen; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and pyriproxyfen to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

-

Page/Page column 221, (2011/05/06)

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a pyrethroid compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a pyrethroid compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

-

Page/Page column 220, (2011/05/06)

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and pyridalyl; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and pyridalyl to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

COMPOSITION AND METHOD FOR CONTROLLING ARTHROPOD PESTS

-

Page/Page column 224, (2011/05/06)

The present invention provides: an arthropod pests control composition comprising, as active ingredients, a condensed heterocyclic compound and a diamide compound; a method for controlling arthropod pests which comprises applying effective amounts of a condensed heterocyclic compound and a diamide compound to the arthropod pests or a locus where the arthropod pests inhabit; and so on.

Pyrazolopyrimidines as therapeutic agents

-

, (2008/06/13)

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Use of NK-1 receptor antagonists for treating major depressive disorders

-

, (2008/06/13)

The present invention provides methods for the treatment of major depressive disorders comprising oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such a NK-1 receptor

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 129644-56-0